Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) FCF Margin (2016 - 2025)

Historic FCF Margin for Outlook Therapeutics (OTLK) over the last 6 years, with Q3 2025 value amounting to 13484.7%.

  • Outlook Therapeutics' FCF Margin changed N/A to 13484.7% in Q3 2025 from the same period last year, while for Dec 2025 it was 3947.64%, marking a year-over-year decrease of 49629800.0%. This contributed to the annual value of 3666.65% for FY2025, which is 58457700.0% down from last year.
  • Latest data reveals that Outlook Therapeutics reported FCF Margin of 13484.7% as of Q3 2025.
  • Over the past 5 years, Outlook Therapeutics' FCF Margin peaked at 13484.7% during Q3 2025, and registered a low of 790.61% during Q2 2025.